Filing Flows › Morgan Stanley (MS) › Stock forecast & fair value
Morgan Stanley (MS) stock forecast and fair value
Morgan Stanley (MS) trades at $182.44. 22 analysts' median price target is $206.50 (+13%), from $185.00 to $262.00. Across 19 valuation methods the middle fair value is $112.07 (-39%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $154.21 | $186.17 | $245.89 | +2% |
| P/E vs peers, weighted | $164.36 | $268.54 | $366.75 | +47% |
| P/E vs peers, matched | $158.68 | $206.01 | $341.75 | +13% |
| EV/Sales vs peers | −$80.44 | −$36.88 | $149.72 | -120% |
| EV/Sales vs peers, weighted | −$27.51 | $152.30 | $214.48 | -17% |
| EV/Sales vs peers, matched | −$90.63 | −$54.57 | $99.41 | -130% |
| Residual income | $89.87 | $93.12 | $96.55 | -49% |
| Analysts' price targets | $185.00 | $211.50 | $262.00 | +16% |
| Our model (Rotation forecast) | $171.10 | $185.73 | $201.60 | +2% |
| Owner earnings capitalized | $170.31 | $190.23 | $215.42 | +4% |
Morgan Stanley's latest quarter
Morgan Stanley, Q3 2026: revenue $20.3B (+12% year over year), operating margin 31.9%, net earnings $4.9B, operating cash flow −$46.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for MS stock?
The median of 22 analysts' 12-month targets is $206.50, +13% from $182.44; the range is $185.00 to $262.00. The average rating is buy.
What is Morgan Stanley's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between −$54.57 and $268.54, with a middle value of $112.07 against a price of $182.44. Each method's assumptions are on the page.
Does Morgan Stanley usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is MS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.